User profiles for K. Flaherty

Flaherty K

Massachusetts General Hospital, University of Pennsylvania
Verified email at mgh.harvard.edu
Cited by 124841

Acute exacerbations of idiopathic pulmonary fibrosis

HR Collard, BB Moore, KR Flaherty… - American journal of …, 2007 - atsjournals.org
The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady,
predictable decline in lung function over time. Recent evidence suggests that some …

Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report

…, J Behr, KK Brown, V Cottin, KR Flaherty… - American journal of …, 2016 - atsjournals.org
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

[HTML][HTML] Mechanisms of resistance to immune checkpoint inhibitors

RW Jenkins, DA Barbie, KT Flaherty - British journal of cancer, 2018 - nature.com
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …

Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

…, AMM Eggermont, KT Flaherty… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE To update the melanoma staging system of the
American Joint Committee on Cancer (AJCC) a large database was assembled comprising >…

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

…, TV Colby, JF Cordier, KR Flaherty… - American journal of …, 2011 - atsjournals.org
This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …

[HTML][HTML] Final version of 2009 AJCC melanoma staging and classification

…, S Ding, AM Eggermont, KT Flaherty… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose To revise the staging system for cutaneous melanoma on the basis of data from an
expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database. …

An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …

…, M Drent, RF Dudden, J Egan, K Flaherty… - American journal of …, 2013 - atsjournals.org
Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS)
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …

[HTML][HTML] Improved survival with vemurafenib in melanoma with BRAF V600E mutation

…, B Nelson, J Hou, RJ Lee, KT Flaherty… - … England Journal of …, 2011 - Mass Medical Soc
Background Phase 1 and 2 clinical trials of the BRAF kinase inhibitor vemurafenib (PLX4032)
have shown response rates of more than 50% in patients with metastatic melanoma with …

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

…, M Bertagnolli, PK Sorger, RJ Sullivan, KT Flaherty… - Science, 2016 - science.org
To explore the distinct genotypic and phenotypic states of melanoma tumors, we applied
single-cell RNA sequencing (RNA-seq) to 4645 single cells isolated from 19 patients, profiling …

[HTML][HTML] Inhibition of mutated, activated BRAF in metastatic melanoma

KT Flaherty, I Puzanov, KB Kim, A Ribas… - … England Journal of …, 2010 - Mass Medical Soc
Background The identification of somatic mutations in the gene encoding the serine–threonine
protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to test …